TY - JOUR T1 - Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics JF - medRxiv DO - 10.1101/2021.01.15.21249881 SP - 2021.01.15.21249881 AU - Kevin C. Ma AU - Tigist F. Menkir AU - Stephen Kissler AU - Yonatan H. Grad AU - Marc Lipsitch Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/15/2021.01.15.21249881.abstract N2 - The impact of variable infection risk by race and ethnicity on the dynamics of SARS-CoV-2 spread is largely unknown. Here, we fit structured compartmental models to seroprevalence data from New York State and analyze how herd immunity thresholds (HITs), final sizes, and epidemic risk changes across racial and ethnic groups. A proportionate mixing model reduced the overall HIT, but more realistic levels of assortative mixing increased the threshold. Across all models, the burden of infection fell disproportionately on minority populations: in an assortative mixing model fit to Long Island census data, 80% of Hispanics or Latinos were infected when the HIT is reached compared to 33% of non-Hispanic whites. Our findings, which are meant to be illustrative and not best estimates, demonstrate how racial and ethnic disparities can impact epidemic trajectories and result in a dis-proportionate distribution of the burden of SARS-CoV-2 infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementK.C.M. was supported by National Science Foundation GRFP grant DGE1745303. Y.H.G. and M.L. were funded by the Morris-Singer Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not human subjects research All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data to reproduce all analyses and figures is available at https://github.com/kevincma/covid19-race-ethnicity-model. An executable version of the Jupyter notebook is available at https://mybinder.org/v2/gh/kevincma/covid19-race-ethnicity-model/HEAD. ER -